Chlamydia trachomatis: the persistent pathogen
SS Witkin, E Minis, A Athanasiou, J Leizer… - Clinical and Vaccine …, 2017 - Am Soc Microbiol
Chlamydia trachomatis is an obligate intracellular bacterium whose only natural host is
humans. Although presenting as asymptomatic in most women, genital tract chlamydial …
humans. Although presenting as asymptomatic in most women, genital tract chlamydial …
[HTML][HTML] Seventy years of Chlamydia vaccine research–limitations of the past and directions for the future
S Phillips, BL Quigley, P Timms - Frontiers in microbiology, 2019 - frontiersin.org
Chlamydia is a major bacterial pathogen that infects humans, as well as a wide range of
animals, including marsupials, birds, cats, pigs, cattle and sheep. Antibiotics are the only …
animals, including marsupials, birds, cats, pigs, cattle and sheep. Antibiotics are the only …
Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised …
Background Chlamydia is the most common sexually transmitted bacterial infection
worldwide. National screening programmes and antibiotic treatment have failed to decrease …
worldwide. National screening programmes and antibiotic treatment have failed to decrease …
Designing a Multi-Epitope Vaccine against Chlamydia trachomatis by Employing Integrated Core Proteomics, Immuno-Informatics and In Silico Approaches
Simple Summary Chlamydia trachomatis is the most common cause of blindness, ectopic
pregnancy, and bacterial sexually transmitted infections. These diseases affect mostly young …
pregnancy, and bacterial sexually transmitted infections. These diseases affect mostly young …
[HTML][HTML] Chlamydia trachomatis: Cell biology, immunology and vaccination
Chlamydia trachomatis is the causative agent of a highly prevalent sexually transmitted
bacterial disease and is associated with a number of severe disease complications. Current …
bacterial disease and is associated with a number of severe disease complications. Current …
Effect of Chlamydia trachomatis on adverse pregnancy outcomes: a meta-analysis
W He, Y Jin, H Zhu, Y Zheng, J Qian - Archives of Gynecology and …, 2020 - Springer
Purpose To analyze the effect of Chlamydia trachomatis (C. trachomatis) on adverse
pregnancy outcomes based on the currently available evidence. Methods Multiple …
pregnancy outcomes based on the currently available evidence. Methods Multiple …
Salmonid antibacterial immunity: An aquaculture perspective
Simple Summary Capture fisheries are reaching their limit, so the increasing demand for fish
protein can only be met through aquaculture. One attractive sector within this industry is the …
protein can only be met through aquaculture. One attractive sector within this industry is the …
Natural-product-based solutions for tropical infectious diseases
About half of the world's population and 80% of the world's biodiversity can be found in the
tropics. Many diseases are specific to the tropics, with at least 41 diseases caused by …
tropics. Many diseases are specific to the tropics, with at least 41 diseases caused by …
[HTML][HTML] Th1 cells are dispensable for primary clearance of Chlamydia from the female reproductive tract of mice
JA Rixon, CE Depew, SJ McSorley - PLoS pathogens, 2022 - journals.plos.org
Protective immune responses to Chlamydia infection within the female reproductive tract
(FRT) are incompletely understood. MHC class II-restricted CD4 Th1 responses are believed …
(FRT) are incompletely understood. MHC class II-restricted CD4 Th1 responses are believed …
Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?
LM de la Maza, TL Darville, S Pal - Expert review of vaccines, 2021 - Taylor & Francis
Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. Antibiotic treatment does not prevent against reinfection and a …
pathogen in the world. Antibiotic treatment does not prevent against reinfection and a …